EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Biofilm-producing and carbapenems-resistant Escherichia coli nosocomial uropathogens: a cross-sectional study

Doaa Abo-Alella, Wessam Abdelmoniem, Enas Tantawy, Ahmed Asaad

International Microbiology · 2024

DOI: 10.1007/s10123-024-00495-w ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Microbiology, 2024. Verfasst von Doaa Abo-Alella und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Hauptthemen laut MEDLINE: Biofilms, Cross Infection, Escherichia coli Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zagazig University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This cross-sectional study aims to determine the incidence and potential risk factors associated with biofilm-producing uropathogenic Escherichia coli (UPEC) nosocomial strains from a tertiary care hospital and to examine the prospective correlation between biofilm generation and antibiotic resistance phenotypes and genotypes.

Methods

A total of 130 UPEC nosocomial isolates were identified, their biofilm formation was quantified using a modified microtiter plate assay, and their antibiotic susceptibilities were assessed utilizing the disc diffusion method. Isolates were then subjected to PCR assays targeting bla KPC , bla VIM , bla IMP , and bla OXA48 genes.

Results

Over half of the isolates ( n = 76, 58.5%) were biofilm producers. Among 17 carbapenem-resistant isolates, 6 (42.9%) isolates harbored the bla OXA48 gene, and only 1 (9.1%) isolate was positive for the bla VIM gene. Prior antibiotic therapy (aOR 15.782, p 0.000) and diabetes mellitus DM (aOR 11.222, p 0.016) were the significant risk factors associated with biofilm production, as determined by logistic regression analysis of the data. In addition, gentamicin resistance was the only statistically significant antibiotic resistance pattern associated with biofilm production (aOR 9.113, p 0.02).

Conclusions

The findings of this study emphasize the significance of implementing proper infection control measures to avoid the horizontal spread of biofilm formation and associated antimicrobial resistance patterns among UPEC nosocomial strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsCross InfectionEscherichia coli InfectionsAnti-Bacterial AgentsUropathogenic Escherichia coliUrinary Tract InfectionsHumansCross-Sectional StudiesFemaleMaleMiddle AgedCarbapenemsAdultAgedRisk FactorsMicrobial Sensitivity Testsbeta-LactamasesTertiary Care Centers

Stichwörter der Autor:innen

E. coliBiofilmCarbapenem resistanceUPECUropathogens

Substanzen

Anti-Bacterial AgentsCarbapenemsbeta-Lactamases

Autor:innen und Institutionen

  • Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. ahmedasaad@zu.edu.eg.

Förderung

  • Zagazig University

Zitieren

APA

Abo-Alella, D., Abdelmoniem, W., Tantawy, E., & Asaad, A. (2024). Biofilm-producing and carbapenems-resistant Escherichia coli nosocomial uropathogens: a cross-sectional study. International Microbiology. https://doi.org/10.1007/s10123-024-00495-w

Vancouver

Abo-Alella D, Abdelmoniem W, Tantawy E, Asaad A. Biofilm-producing and carbapenems-resistant Escherichia coli nosocomial uropathogens: a cross-sectional study. International Microbiology. 2024. doi:10.1007/s10123-024-00495-w

BibTeX
@article{AboAlella2024,
  author = {Abo-Alella, Doaa and Abdelmoniem, Wessam and Tantawy, Enas and Asaad, Ahmed},
  title = {Biofilm-producing and carbapenems-resistant Escherichia coli nosocomial uropathogens: a cross-sectional study},
  journal = {International Microbiology},
  year = {2024},
  doi = {10.1007/s10123-024-00495-w}
}
Kostenlos starten →